Yanting Shi

State Key Laboratory Of Holistic Integrative Management Of Gastrointestinal Cancers And National Clinical Research Center For Digestive Diseases
Xi'an, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Sweet's syndrome during anti-TNF therapy with successful rescue using a JAK inhibitor in refractory ulcerative colitis: a case report and literature review.

Sweet's syndrome during anti-TNF therapy with successful rescue using a JAK inhibitor in refractory ulcerative colitis: a case report and literature review.

Journal: Frontiers in immunology

Published: April 13, 2026

When intestinal ulceration meets hematologic malignancies: clinical features and mortality from a pooled individual-patient data systematic review.

When intestinal ulceration meets hematologic malignancies: clinical features and mortality from a pooled individual-patient data systematic review.

Journal: Frontiers in immunology

Published: February 11, 2026

Dual-targeted therapy for the management of refractory Crohn's disease: a retrospective cohort study.

Dual-targeted therapy for the management of refractory Crohn's disease: a retrospective cohort study.

Journal: Clinical and experimental medicine

Published: March 11, 2025

Opportunistic infections changed before and after SARS-CoV-2 infection in inflammatory bowel disease patients: a retrospective single-center study in China.

Opportunistic infections changed before and after SARS-CoV-2 infection in inflammatory bowel disease patients: a retrospective single-center study in China.

Journal: Frontiers in medicine

Published: August 31, 2024

Establishment and internal validation of a model to predict the efficacy of Adalimumab in Crohn's disease.

Establishment and internal validation of a model to predict the efficacy of Adalimumab in Crohn's disease.

Journal: Scientific reports

Published: August 18, 2024

The Mysterious Cause of Refractory Diarrhea and Weight Loss in a Young Woman.

The Mysterious Cause of Refractory Diarrhea and Weight Loss in a Young Woman.

Journal: Gastroenterology

Published: June 28, 2024

Effectiveness and safety of upadacitinib in acute severe ulcerative colitis patients from single Chinese IBD Center: a monocentric study.

Effectiveness and safety of upadacitinib in acute severe ulcerative colitis patients from single Chinese IBD Center: a monocentric study.

Journal: Clinical and experimental medicine

Published: June 27, 2024

Accumulation of typical persistent organic pollutants and heavy metals in bioretention facilities: Distribution, risk assessment, and microbial community impact.

Accumulation of typical persistent organic pollutants and heavy metals in bioretention facilities: Distribution, risk assessment, and microbial community impact.

Journal: Environmental research

Published: February 27, 2024

Efficacy and safety of adalimumab biosimilar (HS016) in inflammatory bowel disease from the real-world study.

Efficacy and safety of adalimumab biosimilar (HS016) in inflammatory bowel disease from the real-world study.

Journal: Frontiers in pharmacology

Published: July 15, 2023

The change of healthcare service in Chinese patients with inflammatory bowel disease during the pandemic: a national multicenter cross-sectional study.

The change of healthcare service in Chinese patients with inflammatory bowel disease during the pandemic: a national multicenter cross-sectional study.

Journal: Scientific reports

Published: July 07, 2023

Successful treatment of a refractory intestinal Behcet's disease with an oncology history by Vedolizumab: a case report and literature review.

Successful treatment of a refractory intestinal Behcet's disease with an oncology history by Vedolizumab: a case report and literature review.

Journal: Frontiers in immunology

Published: April 13, 2023

Systematic Review and Meta-Analysis of Observational Studies on the Effectiveness and Safety of Ustekinumab among Patients with Inflammatory Bowel Disease in Eastern and Western Countries.

Systematic Review and Meta-Analysis of Observational Studies on the Effectiveness and Safety of Ustekinumab among Patients with Inflammatory Bowel Disease in Eastern and Western Countries.

Journal: Journal of clinical medicine

Published: February 02, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026